loader
Please Wait
Applying Filters...

List of Certificates of Suitability (CEPs) for r1_cep_2014_125___rev_01 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1NORAMCO, LLC. Wilmington US

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNoramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.

R1-CEP 2014-125 - Rev 01
Valid
Chemical
2021-02-24
729
Noramco

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNoramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.

Certificate Number : R1-CEP 2014-125 - Rev 01

Status : Valid

Issue Date : 2021-02-24

Type : Chemical

Substance Number : 729

Noramco

Looking for Certificates of Suitability (CEPs) for R1-CEP 2014-125 - Rev 01 of Noramco, Llc. Wilmington Us

Looking for Certificates of Suitability (CEPs) for R1-CEP 2014-125 - Rev 01 of Noramco, Llc. Wilmington Us 1

20

Noramco, Llc. Wilmington Us, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

They are recognized for Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.

One of their significant offerings is Naloxone hydrochloride dihydrate, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2014-125 - Rev 01

This Chemical Type CEP, issued on February 24, 2021, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

Substance Number 729 associated with this CEP further emphasizes